Articles Posted in Mass Torts

In many ways, 2024 was an anti-climatic year in the world of mass torts. The 3M Earplugs settlement has been a disappointment for thousands of claimants. The rejection of J&J’s efforts to force the talc claims into bankruptcy has not prompted a major settlement and the hernia mesh claims continue to drag on. We did get a major global settlement in the AFFF litigation, but it only covered water contamination claims by local municipalities.

Let’s talk about what we can expect in 2025 in the mass tort class action lawsuits with the highest predicted settlement payouts.

Roundup

Our lawyers are handling Taxotere eye injury lawsuits throughout the United States for women with permanently watery eyes from docetaxel.

Taxotere (docetaxel) is a widely used breast cancer chemotherapy drug. New evidence has emerged showing that Taxotere may be causing some users to suffer permanent vision loss or damage.

This has led to a wave of product liability Taxotere lawsuits by women who claim that Taxotere damaged their eyesight. The manufacturer of Taxotere, Sanofi, allegedly knew about the risk of vision damage but chose not to warn doctors or patients about this risk.

The OneWheel is an electric skateboard product made by Future Motion Inc. The OneWheel features a large single wheel in the center of the board powered by an electric motor. Some Onewheel skateboards contain an apparent defect that causes them to stop suddenly and unexpectedly in mid-motion. When this happens, it can throw the rider off and cause severe injuries.

A growing number of product liability lawsuits are being filed against Future Motion by riders injured by the sudden stop defect in the OneWheel device. These lawsuits have been consolidated into a class action MDL. Settlement talks have already begun in these lawsuits. This page will provide the latest news and updates on this litigation, as well as our predictions on the potential settlement value of these cases.

OneWheel Lawsuit Updates

The promise of Leqembi and Kisunla—drugs that aim not just to ease symptoms but to slow Alzheimer’s disease—was compelling. Alzheimer’s is an awful disease. But as reports emerge of serious brain injuries among clinical trial participants, including bleeding and swelling. Victims who have suffered injuries in these clinical trials may have potential lawsuits for injuries because they were not fully informed of their potential genetic risks before enrolling.

This is very new litigation.  This page explains how potential Leqembia and Kisunla lawsuits might work and what they would involve.  If you have a potential brain bleed or brain injury lawsuit, call us today at 800-553-8082 or get a free consultation online.

Alzheimer’s Treatments with a Double-Edged Sword